| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| DVV00503A |
Research Grade Anti-SARS-CoV-2 S2 subunit SH Neutralizing (WS6) mAb |
100 µg |
$405.00
|
 |
BUY
|
| DVV00332A |
Research Grade Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2) |
100 µg |
$475.00
|
|
BUY
|
| DVV00332B |
Research Grade Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00318B |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2E12) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00318A |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2E12) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00317A |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00317B |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00317X-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
0.5 mg |
$1,485.00
|
|
BUY
|
| DVV00317B-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
1.0 mg |
$2,310.00
|
|
BUY
|
| DHJ42801B |
Research Grade Anumigilimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ42801A |
Research Grade Anumigilimab |
100 ug |
$420.00
|
|
BUY
|
| DHC34001A |
Research Grade Apamistamab |
100 ug |
$380.00
|
|
BUY
|
| DHC34001B |
Research Grade Apamistamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47902B |
Research Grade Aprutumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47902A |
Research Grade Aprutumab |
100 ug |
$380.00
|
|
BUY
|
| RHC21001A |
Research Grade Arcitumomab |
100 µg |
$420.00
|
|
BUY
|
| RHC21001B |
Research Grade Arcitumomab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHE20501A |
Research Grade Ascrinvacumab |
100 ug |
$420.00
|
|
BUY
|
| DHE20501B |
Research Grade Ascrinvacumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD03301A |
Research Grade Aselizumab |
100 ug |
$380.00
|
|
BUY
|
| DHD03301B |
Research Grade Aselizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHF88301A |
Research Grade Astegolimab |
100 ug |
$380.00
|
|
BUY
|
| DHF88301B |
Research Grade Astegolimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ70101B |
Research Grade Atezolizumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ70101A |
Research Grade Atezolizumab |
100 ug |
$420.00
|
|
BUY
|
| DHC33701A |
Research Grade Atibuclimab |
100 ug |
$380.00
|
|
BUY
|
| DHC33701B |
Research Grade Atibuclimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DXX00103B |
Research Grade Atidortoxumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DXX00103A |
Research Grade Atidortoxumab |
100 ug |
$380.00
|
|
BUY
|
| DVV03606B |
Research Grade Atoltivimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV03606A |
Research Grade Atoltivimab |
100 ug |
$420.00
|
|
BUY
|
| DHF92101B |
Research Grade Atorolimumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHF92101A |
Research Grade Atorolimumab |
100 ug |
$380.00
|
|
BUY
|
| DHD47201A |
Research Grade Avdoralimab |
100 ug |
$380.00
|
|
BUY
|
| DHD47201B |
Research Grade Avdoralimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ70103A |
Research Grade Avelumab |
100 µg |
$420.00
|
|
BUY
|
| DHJ70103B |
Research Grade Avelumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ59401B |
Research Grade Avizakimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ59401A |
Research Grade Avizakimab |
100 ug |
$380.00
|
|
BUY
|
| DHC25203B |
Research Grade Axatilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC25203A |
Research Grade Axatilimab |
100 ug |
$380.00
|
|
BUY
|
| DHJ64002A |
Research Grade Azintuxizumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ64002B |
Research Grade Azintuxizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHB86919B |
Research Grade Bafisontamab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHB86919A |
Research Grade Bafisontamab |
100 ug |
$420.00
|
|
BUY
|
| DHH02203A |
Research Grade Balstilimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02203B |
Research Grade Balstilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DVV00303B |
Research Grade Bamlanivimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00303A |
Research Grade Bamlanivimab |
100 ug |
$420.00
|
|
BUY
|
| DHC12507B |
Research Grade Bapineuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC12507A |
Research Grade Bapineuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD48406B |
Research Grade Barecetamab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD48406A |
Research Grade Barecetamab |
100 ug |
$420.00
|
|
BUY
|
| DHC83101B |
Research Grade Barzolvolimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHC83101A |
Research Grade Barzolvolimab |
100 ug |
$420.00
|
|
BUY
|
| DHB95802A |
Research Grade Basiliximab |
100 ug |
$420.00
|
|
BUY
|
| DHB95802B |
Research Grade Basiliximab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHF14603A |
Research Grade Batoclimab |
100 ug |
$380.00
|
|
BUY
|
| DHF14603B |
Research Grade Batoclimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DVV00319B |
Research Grade Bebtelovimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00319A |
Research Grade Bebtelovimab |
100 µg |
$420.00
|
|
BUY
|
| DHD38504A |
Research Grade Bectumomab |
100 ug |
$490.00
|
|
BUY
|
| DHD38504B |
Research Grade Bectumomab |
1.0 mg |
$1,790.00
|
|
BUY
|
| DQB91701B |
Research Grade Bedinvetmab |
1.0 mg |
$1,715.00
|
|
BUY
|
| DQB91701A |
Research Grade Bedinvetmab |
100 µg |
$475.00
|
|
BUY
|
| DHC82801A |
Research Grade Befovacimab |
100 ug |
$380.00
|
|
BUY
|
| DHC82801B |
Research Grade Befovacimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD74101A |
Research Grade Begelomab |
100 ug |
$380.00
|
|
BUY
|
| DHD74101B |
Research Grade Begelomab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHF92401A |
Research Grade Belantamab |
100 ug |
$420.00
|
|
BUY
|
| DHF92401B |
Research Grade Belantamab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ85301A |
Research Grade Belimumab |
100 ug |
$420.00
|
|
BUY
|
| DHJ85301B |
Research Grade Belimumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00309A |
Research Grade Beludavimab |
100 ug |
$420.00
|
|
BUY
|
| DVV00309B |
Research Grade Beludavimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD47901A |
Research Grade Bemarituzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD47901B |
Research Grade Bemarituzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHF86301A |
Research Grade Benralizumab |
100 ug |
$475.00
|
|
BUY
|
| DHF86301B |
Research Grade Benralizumab |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHA29101B |
Research Grade Benufutamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHA29101A |
Research Grade Benufutamab |
100 ug |
$380.00
|
|
BUY
|
| DHC82405A |
Research Grade Bepranemab |
100 ug |
$420.00
|
|
BUY
|
| DHC82405B |
Research Grade Bepranemab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DXX00801A |
Research Grade Berlimatoxumab |
100 ug |
$420.00
|
|
BUY
|
| DXX00801B |
Research Grade Berlimatoxumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHB95501B |
Research Grade Bermekimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHB95501A |
Research Grade Bermekimab |
100 ug |
$380.00
|
|
BUY
|
| DHC16001B |
Research Grade Bersanlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC16001A |
Research Grade Bersanlimab |
100 ug |
$380.00
|
|
BUY
|
| DHE85001A |
Research Grade Bertilimumab |
100 ug |
$420.00
|
|
BUY
|
| DHE85001B |
Research Grade Bertilimumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD98101A |
Research Grade Besilesomab |
100 ug |
$380.00
|
|
BUY
|
| DHD98101B |
Research Grade Besilesomab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ70119B |
Research Grade Betifisolimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ70119A |
Research Grade Betifisolimab |
100 µg |
$420.00
|
|
BUY
|
| DHD12602B |
Research Grade Bevacizumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD12602A |
Research Grade Bevacizumab |
100 ug |
$420.00
|
|
BUY
|
| DXX00301A |
Research Grade Bezlotoxumab |
100 µg |
$420.00
|
|
BUY
|
| DXX00301B |
Research Grade Bezlotoxumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHB99201A |
Research Grade Biciromab |
100 ug |
$380.00
|
|
BUY
|
